{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T19:17:58Z","timestamp":1776539878995,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00432-013-1414-4","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T18:28:35Z","timestamp":1363372115000},"page":"1025-1031","source":"Crossref","is-referenced-by-count":7,"title":["Survey on the worldwide Chronic Myeloid Leukemia Advocates Network regarding complementary and alternative medicine"],"prefix":"10.1007","volume":"139","author":[{"given":"Thomas","family":"Elsner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Muecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Micke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz J.","family":"Prott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Muenstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"1414_CR1","unstructured":"American Cancer Society (2013) http:\/\/www.cancer.org\/treatment\/treatmentsandsideeffects\/complementaryandalternativemedicine\/guidelines-for-using-complementary-and-alternative-methods ; Assessed 26.02.2013"},{"issue":"2","key":"1414_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1363459307086841","volume":"12","author":"A Broom","year":"2008","unstructured":"Broom A, Tovey P (2008) The role of the Internet in cancer patients\u2019 engagement with complementary and alternative treatments. Health (London) 12(2):139\u2013155","journal-title":"Health (London)"},{"issue":"5","key":"1414_CR3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1634\/theoncologist.2012-0149","volume":"17","author":"BR Cassileth","year":"2012","unstructured":"Cassileth BR (2012) Alternative therapies: learning from patients who choose them. Oncologist 17(5):590\u2013591","journal-title":"Oncologist"},{"issue":"23","key":"1414_CR4","first-page":"4810","volume":"22","author":"GK Dy","year":"2000","unstructured":"Dy GK, Bekele L, Hanson LJ, Furth A, Mandrekar S, Sloan JA et al (2000) Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 22(23):4810\u20134815","journal-title":"J Clin Oncol"},{"key":"1414_CR5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/1534735403256207","volume":"2","author":"J Eng","year":"2003","unstructured":"Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2:212\u2013216","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"1414_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1534735407309257","volume":"6","author":"VS Eschiti","year":"2007","unstructured":"Eschiti VS (2007) Lesson from comparison of CAM use by women with female-specific cancers to others: it\u2018s time to focus on interaction risks with CAM therapies. Integr Cancer Ther 6(4):313\u2013344","journal-title":"Integr Cancer Ther"},{"issue":"6","key":"1414_CR7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3322\/canjclin.53.6.356","volume":"53","author":"G Eysenbach","year":"2003","unstructured":"Eysenbach G (2003) The impact of the Internet on cancer outcomes. CA Cancer J Clin 53(6):356\u2013371","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1414_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1534735406291494","volume":"5","author":"D Hann","year":"2006","unstructured":"Hann D, Allen S, Ciambrone D, Shah A (2006) Use of complementary therapies during chemotherapy: influence of patients\u2018satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther 5(3):224\u2013231","journal-title":"Integr Cancer Ther"},{"issue":"19","key":"1414_CR9","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1158\/0008-5472.CAN-08-1490","volume":"68","author":"ML Heaney","year":"2008","unstructured":"Heaney ML (2008) Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 68(19):8031\u20138038","journal-title":"Cancer Res"},{"key":"1414_CR10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.2005.03.9800","volume":"25","author":"FJ Hlubocky","year":"2007","unstructured":"Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK (2007) Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life and preferences for decision making. J Clin Oncol 25:548\u2013554","journal-title":"J Clin Oncol"},{"key":"1414_CR11","unstructured":"Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2011) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. PMID: 22019489"},{"issue":"4","key":"1414_CR12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0277-9536(02)00086-2","volume":"56","author":"H Kakai","year":"2003","unstructured":"Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Tasaki K (2003) Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis.\u201d. Soc Sci Med 56(4):851\u2013862","journal-title":"Soc Sci Med"},{"key":"1414_CR13","first-page":"235","volume":"5","author":"C Maddock","year":"2011","unstructured":"Maddock C, Lewis I, Ahmad K, Sullivan R (2011) Online information needs of cancer patients and their organizations. Ecancer 5:235. doi: 10.3332\/ecancer.2011.235","journal-title":"Ecancer"},{"issue":"6","key":"1414_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/acm.2000.6.531","volume":"6","author":"G Maskarinec","year":"2000","unstructured":"Maskarinec G, Shumay DM, Kakai H, Gotay CC (2000) Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 6(6):531\u2013538","journal-title":"J Altern Complement Med"},{"issue":"2","key":"1414_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/appi.psy.44.2.100","volume":"44","author":"SC Matthews","year":"2003","unstructured":"Matthews SC, Camacho A, Mills PJ, Dimsdale JE (2003) The internet for medical information about cancer: help or hindrance? Psychosomatics 44(2):100\u2013103","journal-title":"Psychosomatics"},{"key":"1414_CR16","first-page":"22","volume":"1","author":"O Micke","year":"2009","unstructured":"Micke O, Bruns F, Glatzel M, Sch\u00f6nekaes K, Micke P, M\u00fccke R et al (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:22\u201330","journal-title":"Eur J Integr Med"},{"key":"1414_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000262477","volume":"42","author":"O Micke","year":"2010","unstructured":"Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R (2010) Complementary and alternative medicine in lung cancer patients: a neglected phenomenon? Front Radiat Ther Oncol 42:198\u2013205","journal-title":"Front Radiat Ther Oncol"},{"key":"1414_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1188\/09.ONF.61-68","volume":"36","author":"PE Miller","year":"2009","unstructured":"Miller PE, Vasey JJ, Short PF, Hartman TJ (2009) Dietary supplement use in adult cancer survivors. Oncol Nurs Forum 36:61\u201368","journal-title":"Oncol Nurs Forum"},{"key":"1414_CR19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdi110","volume":"16","author":"A Molassiotis","year":"2005","unstructured":"Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V et al (2005a) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655\u2013663","journal-title":"Ann Oncol"},{"issue":"2","key":"1414_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ctcp.2004.12.005","volume":"11","author":"A Molassiotis","year":"2005","unstructured":"Molassiotis A, Margulies A, Fernandez-Ortega P, Pud D, Panteli V, Bruyns I (2005b) Complementary and alternative medicine use in patients with haematological malignancies in Europe. Complement Ther Clin Pract 11(2):105\u2013110","journal-title":"Complement Ther Clin Pract"},{"issue":"22","key":"1414_CR21","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1002\/cncr.26164","volume":"117","author":"A Naing","year":"2011","unstructured":"Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X et al (2011) Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD anderson cancer center experience. Cancer 117(22):5142\u20135150","journal-title":"Cancer"},{"key":"1414_CR22","unstructured":"NCCAM (2013) http:\/\/nccam.nih.gov\/about ; Assessed 26.02.2013"},{"issue":"6","key":"1414_CR23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","volume":"22","author":"A Puissant","year":"2008","unstructured":"Puissant A (2008) Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. FASEB J 22(6):1894\u20131904","journal-title":"FASEB J"},{"issue":"4","key":"1414_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00520-010-0846-5","volume":"19","author":"SM Rausch","year":"2011","unstructured":"Rausch SM, Winegardner F, Kruk KM, Phatak V, Wahner-Roedler DL, Bauer B, Vincent A (2011) Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Support Care Cancer 19(4):521\u2013529","journal-title":"Support Care Cancer"},{"issue":"2-3","key":"1414_CR25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctim.2004.09.006","volume":"12","author":"A Robinson","year":"2004","unstructured":"Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12(2-3):90\u201398","journal-title":"Complement Ther Med"},{"issue":"3","key":"1414_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1534735408323081","volume":"7","author":"GA Saxe","year":"2008","unstructured":"Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the women\u2018s healthy eating and living study. Integr Cancer Ther 7(3):122\u2013127","journal-title":"Integr Cancer Ther"},{"key":"1414_CR27","doi-asserted-by":"crossref","unstructured":"Shatzer AN, Espey MG, Chavez M, Tu H, Levine M, Cohen JI (2012) Ascorbic acid kills epstein-barr virus positive burkitt lymphoma cells and epstein-barr virus transformed B-cells in vitro, but not in vivo. Leuk Lymphoma. (Epub ahead of print)","DOI":"10.3109\/10428194.2012.739686"},{"key":"1414_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.24095\/hpcdp.29.2.06","volume":"29","author":"MJ Verhoef","year":"2009","unstructured":"Verhoef MJ, Trojan L, Armitage GD, Carlson L, Hilsden RJ (2009) Complementary therapies for cancer patients: assessing information use and needs. Chronic Dis Can 29:80\u201388","journal-title":"Chronic Dis Can"},{"key":"1414_CR29","first-page":"357","volume":"139","author":"T Zeller","year":"2012","unstructured":"Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E et al (2012) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center 139:357\u2013365. doi: 10.1007\/s00432-012-1336-6","journal-title":"Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1414-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-013-1414-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1414-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T15:17:39Z","timestamp":1644592659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-013-1414-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1007\/s00432-013-1414-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]}}}